Literature DB >> 22203768

Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.

Sietske B M Gaykema1, Adrienne H Brouwers, Sjoerd Hovenga, Marjolijn N Lub-de Hooge, Elizabeth G E de Vries, Caroline P Schröder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22203768     DOI： 10.1200/JCO.2011.38.0204

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Role of positron emission tomography for the monitoring of response to therapy in breast cancer.

Authors:  Olivier Humbert; Alexandre Cochet; Bruno Coudert; Alina Berriolo-Riedinger; Salim Kanoun; François Brunotte; Pierre Fumoleau
Journal:  Oncologist       Date:  2015-01-05

2.  Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.

Authors:  Adriana V F Massicano; Supum Lee; Bryant K Crenshaw; Tolulope A Aweda; Retta El Sayed; Ian Super; Ron Bose; Bernadette V Marquez-Nostra; Suzanne E Lapi
Journal:  Cancer Biother Radiopharm       Date:  2019-01-24       Impact factor: 3.099

Review 3.  Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging.

Authors:  Simon-Peter Williams
Journal:  AAPS J       Date:  2012-03-31       Impact factor: 4.009

Review 4.  Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.

Authors:  Kelly E Henry; Gary A Ulaner; Jason S Lewis
Journal:  PET Clin       Date:  2017-07

Review 5.  Advances in aptamer-based nuclear imaging.

Authors:  Wenyu Song; Yangmeihui Song; Qian Li; Chunhai Fan; Xiaoli Lan; Dawei Jiang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-08       Impact factor: 10.057

Review 6.  PET radiometals for antibody labeling.

Authors:  Eduardo Aluicio-Sarduy; Paul A Ellison; Todd E Barnhart; Weibo Cai; Robert Jerry Nickles; Jonathan W Engle
Journal:  J Labelled Comp Radiopharm       Date:  2018-03-12       Impact factor: 1.921

Review 7.  Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer.

Authors:  Kelly E Henry; Gary A Ulaner; Jason S Lewis
Journal:  PET Clin       Date:  2018-07

8.  PET Tracers for Clinical Imaging of Breast Cancer.

Authors:  Iván Peñuelas; Inés Domínguez-Prado; María J García-Velloso; Josep M Martí-Climent; Macarena Rodríguez-Fraile; Carlos Caicedo; María Sánchez-Martínez; José A Richter
Journal:  J Oncol       Date:  2012-08-29       Impact factor: 4.375

9.  High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.

Authors:  Claudia T Mendler; Lars Friedrich; Iina Laitinen; Martin Schlapschy; Markus Schwaiger; Hans-Jürgen Wester; Arne Skerra
Journal:  MAbs       Date:  2015       Impact factor: 5.857

10.  Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.

Authors:  Volkan Beylergil; Patrick G Morris; Peter M Smith-Jones; Shanu Modi; David Solit; Clifford A Hudis; Yang Lu; Joseph O'Donoghue; Serge K Lyashchenko; Jorge A Carrasquillo; Steven M Larson; Timothy J Akhurst
Journal:  Nucl Med Commun       Date:  2013-12       Impact factor: 1.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.